Nike Anticipates Fiscal Q2 Earnings Amid 52.6 Percent EPS Decline
Nike Inc (NYSE: NKE) is scheduled to release its fiscal second-quarter financial results on Dec 18, 2025. Market analysts project earnings per share of $0.37, representing a 52.6% decrease compared to the same period in the previous year. Total revenue is expected to reach $12.2 billion, a 1.7% year-over-year decline.
The company continues to implement its Win Now turnaround strategy under the leadership of CEO Elliott Hill. While Nike reports growth in North America and the EMEA regions through wholesale gains and inventory management, it faces significant headwinds in international markets. These challenges include margin pressure from phasing out footwear franchises, higher tariffs, and weakening demand in China.
- North America and EMEA performance is supported by pricing discipline and effective inventory control.
- The Chinese market remains a point of concern for analysts monitoring the company recovery.
- Stock volatility remains high, with an average next-day movement of 9.1% following earnings reports.
Investment metrics for Nike Inc (NYSE: NKE) include a price-to-earnings ratio of 34.23 and a price-to-sales ratio of 2.14. The enterprise value to sales ratio currently stands at 2.22. The stock has experienced a decline of approximately 10% throughout 2025, though it recently showed signs of rebounding from critical support levels.
Further details regarding the corporate trajectory and stability can be found in the NKE and NKE. Analysts also monitor the NKE and the NKE to assess long-term viability during this strategic transition.
NIKE, Inc. (NKE) DCF Excel Template
5-Year Financial Model
40+ Charts & Metrics
DCF & Multiple Valuation
Free Email Support
Disclaimer
All information, articles, and product details provided on this website are for general informational and educational purposes only. We do not claim any ownership over, nor do we intend to infringe upon, any trademarks, copyrights, logos, brand names, or other intellectual property mentioned or depicted on this site. Such intellectual property remains the property of its respective owners, and any references here are made solely for identification or informational purposes, without implying any affiliation, endorsement, or partnership.
We make no representations or warranties, express or implied, regarding the accuracy, completeness, or suitability of any content or products presented. Nothing on this website should be construed as legal, tax, investment, financial, medical, or other professional advice. In addition, no part of this site—including articles or product references—constitutes a solicitation, recommendation, endorsement, advertisement, or offer to buy or sell any securities, franchises, or other financial instruments, particularly in jurisdictions where such activity would be unlawful.
All content is of a general nature and may not address the specific circumstances of any individual or entity. It is not a substitute for professional advice or services. Any actions you take based on the information provided here are strictly at your own risk. You accept full responsibility for any decisions or outcomes arising from your use of this website and agree to release us from any liability in connection with your use of, or reliance upon, the content or products found herein.